MedMira Inc (MIR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, MedMira Inc (MIR) has a cash flow conversion efficiency ratio of 0.006x as of April 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-150.63K ≈ $-108.96K USD) by net assets (CA$-24.52 Million ≈ $-17.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MedMira Inc market capitalisation for the company's overall valuation and market capitalisation.
MedMira Inc - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how MedMira Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
MedMira Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MedMira Inc ranked by their cash flow conversion efficiency. Explore MedMira Inc (MIR) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Big 5 Sporting Goods Corporation
NASDAQ:BGFV
|
-0.258x |
|
ROCA INDUSTRY HOLDINGROCK1 S.A.
RO:ROC1
|
N/A |
|
Carbon Streaming Corp
NEO:NETZ
|
0.003x |
|
Asuransi Harta Aman Pratama Tbk PT
JK:AHAP
|
0.088x |
|
Tocvan Ventures Corp
F:TV3
|
-0.046x |
|
Ferroamp Elektronik AB
ST:FERRO
|
-0.003x |
|
Grace Therapeutics, Inc.
NASDAQ:GRCE
|
-0.034x |
|
Soktas Tekstil Sanayi ve Ticaret AS
IS:SKTAS
|
0.124x |
Annual Cash Flow Conversion Efficiency for MedMira Inc (2000–2025)
The table below shows the annual cash flow conversion efficiency of MedMira Inc from 2000 to 2025. View MIR live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-07-31 | CA$-22.56 Million ≈ $-16.32 Million |
CA$-3.15 Million ≈ $-2.28 Million |
0.139x | -14.42% |
| 2024-07-31 | CA$-18.04 Million ≈ $-13.05 Million |
CA$-2.94 Million ≈ $-2.13 Million |
0.163x | +93.17% |
| 2023-07-31 | CA$-15.03 Million ≈ $-10.87 Million |
CA$-1.27 Million ≈ $-917.07K |
0.084x | -44.69% |
| 2022-07-31 | CA$-12.36 Million ≈ $-8.94 Million |
CA$-1.88 Million ≈ $-1.36 Million |
0.152x | +375.09% |
| 2021-07-31 | CA$-15.72 Million ≈ $-11.37 Million |
CA$-504.64K ≈ $-365.05K |
0.032x | +58.11% |
| 2020-07-31 | CA$-15.56 Million ≈ $-11.26 Million |
CA$-315.90K ≈ $-228.51K |
0.020x | -70.85% |
| 2019-07-31 | CA$-13.52 Million ≈ $-9.78 Million |
CA$-941.13K ≈ $-680.80K |
0.070x | -0.23% |
| 2018-07-31 | CA$-11.40 Million ≈ $-8.25 Million |
CA$-795.41K ≈ $-575.38K |
0.070x | -66.83% |
| 2017-07-31 | CA$-8.98 Million ≈ $-6.50 Million |
CA$-1.89 Million ≈ $-1.37 Million |
0.210x | -60.61% |
| 2016-07-31 | CA$-7.66 Million ≈ $-5.54 Million |
CA$-4.09 Million ≈ $-2.96 Million |
0.534x | +75.38% |
| 2015-07-31 | CA$-7.70 Million ≈ $-5.57 Million |
CA$-2.35 Million ≈ $-1.70 Million |
0.305x | -56.23% |
| 2014-07-31 | CA$-6.69 Million ≈ $-4.84 Million |
CA$-4.66 Million ≈ $-3.37 Million |
0.696x | +685.62% |
| 2011-07-31 | CA$-19.11 Million ≈ $-13.83 Million |
CA$-1.69 Million ≈ $-1.22 Million |
0.089x | -44.03% |
| 2010-07-31 | CA$-16.66 Million ≈ $-12.05 Million |
CA$-2.64 Million ≈ $-1.91 Million |
0.158x | +25.16% |
| 2009-07-31 | CA$-16.00 Million ≈ $-11.57 Million |
CA$-2.02 Million ≈ $-1.46 Million |
0.126x | -45.46% |
| 2008-07-31 | CA$-13.94 Million ≈ $-10.08 Million |
CA$-3.23 Million ≈ $-2.34 Million |
0.232x | +40.86% |
| 2007-07-31 | CA$-12.78 Million ≈ $-9.24 Million |
CA$-2.10 Million ≈ $-1.52 Million |
0.165x | -82.43% |
| 2006-07-31 | CA$-8.05 Million ≈ $-5.82 Million |
CA$-7.54 Million ≈ $-5.45 Million |
0.937x | +70.96% |
| 2005-07-31 | CA$-9.80 Million ≈ $-7.09 Million |
CA$-5.37 Million ≈ $-3.89 Million |
0.548x | +4.46% |
| 2004-07-31 | CA$-5.87 Million ≈ $-4.25 Million |
CA$-3.08 Million ≈ $-2.23 Million |
0.525x | -61.59% |
| 2003-07-31 | CA$-2.19 Million ≈ $-1.58 Million |
CA$-2.99 Million ≈ $-2.16 Million |
1.366x | +178.17% |
| 2002-07-31 | CA$-7.45 Million ≈ $-5.39 Million |
CA$-3.66 Million ≈ $-2.64 Million |
0.491x | -51.47% |
| 2001-07-31 | CA$-6.01 Million ≈ $-4.35 Million |
CA$-6.08 Million ≈ $-4.40 Million |
1.012x | +8.71% |
| 2000-07-31 | CA$-3.28 Million ≈ $-2.37 Million |
CA$-3.05 Million ≈ $-2.21 Million |
0.931x | -- |
About MedMira Inc
MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or who… Read more